tiprankstipranks
Trinity Biotech Reports Strong Asset Growth
Company Announcements

Trinity Biotech Reports Strong Asset Growth

Trinity Biotech (TRIB) has released an update.

Pick the best stocks and maximize your portfolio:

Trinity Biotech PLC has released its unaudited condensed consolidated financial statements for the period ending June 30, 2024, showing a significant increase in total assets to $94,355,000 from $59,435,000 at the end of the previous year. This financial growth is reflected in the rise of both non-current and current assets, including goodwill, intangible assets, and inventories. Shareholders will note an increase in share capital and share premium, despite a continued accumulated deficit.

For further insights into TRIB stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskTrinity Biotech Gains WHO Approval for Offshore HIV Test Manufacturing
TheFlyTrinity Biotech gets approval from WHO for TrinScreen, Uni-Gold manufacturing
TipRanks Auto-Generated NewsdeskTrinity Biotech Files Prospectus for $1 Million ADS Offering
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App